Bring your research idea and we will make it happen SpacePharma provides pharmaceutical and biological experiments to run under microgravity conditions. This is fully autonomous, AI-powered experiments in space—remotely, affordably, and at scale. Our miniaturized lab-on-a-chip platforms operate on the ISS, CubeSats, and private space missions, unlocking microgravity’s potential for drug discovery, protein development, materials innovation, and life science research. As a pioneer in outer space bioconvergence—the fusion of biology, AI, and space tech—we accelerate breakthroughs that go far beyond Earth’s limits. Since 2017, we've delivered end-to-end research services:exploitations design, spaceflight logistics, real-time remote control, and advanced data analysis. With …

5 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

insitro is the physical AI company built on causal biology. insitro is the physical AI company unlocking causal human biology, founded and led by AI pioneer Daphne Koller. By generating the world’s largest integrated multi-modal corpus of human and cellular data, we’ve built the Virtual HumanTM – a genetically anchored causal AI engine that reveals how disease begins, progresses, and can be resolved. Our platform enables us to precisely identify causal genetic drivers and deploy our TherMLTM AI platform to design optimal medicines, advancing a broad pipeline of therapeutics for neuroscience and metabolic diseases. This industrialized architecture creates a self-learning …

59 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Synthetic Biology

Smarter Tech, Faster Therapies We are dedicated to advancing access to numerous technological innovations, elevating the quality, rigor, and reliability of clinical research rooted in the scientific method. Our commitment is to be instrumental in accelerating drug development, supporting pharmaceutical and biotechnology companies to bring therapies to patients swiftly and efficiently. AI, Machine Learning, Technology, Data, and Adaptive Clinical Trials

268 similar entities Type: Startup Activities: biotech deeptech Technologies: Data Analytics

Grounded in nature, authored by AI Profluent is an AI-first protein design company. Founded in 2022, we develop deep generative models to design and validate novel, functional proteins to revolutionize biomedicine. Based in Emeryville, CA, we are backed by leading investors including Spark Capital, Insight Partners, Air Street Capital, AIX Ventures, and Convergent Ventures. To learn more about our mission to decode the language of life with AI, visit profluent.bio. artificial intelligence, machine learning, biotech, and gene editing

61 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. Synthetic Biology A.I. - Machine Learning Generative A.I.

Beyond Known Biology: AI company dedicated to using nature to solve the life sciences' most pressing challenges - BCR Basecamp Research is an AI company dedicated to solving the most pressing challenges in the life sciences by exploring beyond known biology. The company discovers and designs proteins with artificial intelligence trained on its proprietary knowledge graph of nature, the largest and most diverse of its kind, to design biological solutions for pharma, food and industrial applications. Understanding the full genetic, evolutionary, and environmental context of each protein allows Basecamp Research to design tailored proteins for specific applications without the need …

58 similar entities Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology SaaS A.I.

AI for digital twin of cells DeepLife is an early stage startup founded in 2019 by Jonathan Baptista and Jean-Baptiste Morlot, backed by international investors, developing the first SaaS platform for Digital Twin of cells. While we are able to design and build incredibly complex mechanical engines, engineering biological systems, such as cells, remains a challenge. However, recent technological improvements, notably in biochemistry, recently enabled the construction of databases with millions of quantitative cell activity measures, covering multiple diseases. The DeepLife team develops a SaaS platform combining state-of-the-art deep learning algorithms on multi-omics sequencing data, public and private cell atlases, …

100 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Deep Learning SaaS

Patient-based drug discovery We design and apply unique patient-based cellular assays for large-scale phenotypic screening, leaning on the power of AI-driven image analysis. Integrated from bed to bench and back to bed, we aim to generate most efficient first-in-class therapeutic molecules for next generation medicine. AI image and data analysis, biology, high content screening, high throughput screening, deep learning, assay development, patient stratification, pyschiatric disorders, and cardiac muscle

260 similar entities Type: Startup Activities: biotech deeptech healthtech Technologies: A.I. Synthetic Biology

3D cell shape + AI to bring the right therapies to the right patients sooner Sentinal4D is an AI-powered cancer drug discovery and development company, with close ties to the Institute of Cancer Research. Sentinal4D represents a collaboration of physics, biology and artificial intelligence to drive novel cancer therapy candidates with a high probability of clinical success. Artificial Intelligence, Computer Vision, Systems Biology, and Drug Discovery

103 similar entities Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology

Drug discovery with cutting-edge AI technology We’re pioneering the use of AI and shaping the future in drug discovery, significantly cutting costs and development times. Our unique AI algorithms have generated novel drug candidates and identified enhancements for existing therapies more efficiently than traditional methods, setting us apart in the competitive landscape. Artificial Intelligence, Data Science, Health, Medicines, and Drug development

152 similar entities Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Unlock R&D productivity with the most complete AI platform for life sciences. Our mission at Causaly is to redefine the boundaries of human discovery by harnessing transformative AI technologies. Founded in 2018, Causaly’s unique AI platform is a powerful catalyst for the modern Life Science research organization, reshaping how data is found, analyzed and applied in critical decision-making processes in drug discovery and development. Supporting a broad range of complex knowledge workflows, our platform accelerates the journey from bench research and laboratory insights to the launch of life-changing therapies. Artificial Intelligence, Natural Language Understanding, Knowledge graphs, Pharma, and Life Sciences

41 similar entities Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Natural Language Processing

Unlock genomic insights Emedgene is on a mission to unlock genomic insights for the world’s health organizations by providing data-driven AI solutions for genomic diagnostics and discovery at scale. We work with leading healthcare and life sciences organizations to enable precision medicine programs, enable high throughput diagnostics and accelerate the pace of research. Genomics, Human Genetics, Big Data, and Algorithms

162 similar entities Type: Startup Activities: biotech deeptech it services Technologies: A.I. A.I. - Machine Learning